Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma
Public ClinicalTrials.gov record NCT00529529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-week Treatment, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study to Assess the Safety of Indacaterol (300 and 600 µg o.d.) in Patients With Moderate to Severe Persistent Asthma, Using Salmeterol (50 µg b.i.d.) as an Active Control
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was designed to assess the safety of indacaterol (300 µg and 600 µg (2 x 300 μg capsules) once daily \[od\]), compared with salmeterol (50 μg twice a day \[b.i.d.\]), over 26 weeks, in patients with moderate to severe persistent asthma.
Study identification
- NCT ID
- NCT00529529
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 805 participants
Conditions and interventions
Conditions
Interventions
- Indacaterol 300 μg Drug
- Salmeterol 50 μg Drug
- Placebo to indacaterol Drug
- Placebo to salmeterol Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Aug 2008 (Actual)
- Last update posted
- Aug 29, 2011
2007 – 2008
United States locations
- U.S. sites
- 56
- U.S. states
- 20
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigator Site | Glendale | Arizona | 85306 | — |
| Novartis Investigator Site | Phoenix | Arizona | 85306 | — |
| Novartis Investigator Site | Encinitas | California | 92024 | — |
| Novartis Investigator Site | Huntington Beach | California | 92647 | — |
| Novartis Investigator Site | Long Beach | California | 90806 | — |
| Novartis Investigator Site | Long Beach | California | 90808 | — |
| Novartis Investigator Site | Los Angeles | California | 90025 | — |
| Novartis Investigator Site x 2 sites | Oakland | California | 94609 | — |
| Novartis Investigator Site | Orange | California | 92868 | — |
| Novartis Investigator Site | Palmdale | California | 93551 | — |
| Novartis Investigator Site | San Diego | California | 92120 | — |
| Novartis Investigator Site | San Diego | California | 92123 | — |
| Novartis Investigator Site | Walnut Creek | California | 94598 | — |
| Novartis Investigator Site | Denver | Colorado | 80206 | — |
| Novartis Investigator Site | Denver | Colorado | 80230 | — |
| Novartis Investigator Site | Englewood | Colorado | 80112 | — |
| Novartis Investigator Site | Lakewood | Colorado | 80401 | — |
| Novartis Investigator Site | Brandon | Florida | 33511 | — |
| Novartis Investigator Site | Largo | Florida | 33770 | — |
| Novartis Investigator Site | Miami | Florida | 33143 | — |
| Novartis Investigator Site | Panama City | Florida | 32405 | — |
| Novartis Investigator Site | Pensacola | Florida | 32503 | — |
| Novartis Investigator Site x 2 sites | Pensacola | Florida | 32514 | — |
| Novartis Investigator Site | Tamarac | Florida | 33321 | — |
| Novartis Investigator Site | Albany | Georgia | 31707 | — |
| Novartis Investigator Site | Stockbridge | Georgia | 30281 | — |
| Novartis Investigator Site | Overland Park | Kansas | 66210 | — |
| Novartis Investigator Site | Overland Park | Kansas | 66215 | — |
| Novartis Investigator Site | Topeka | Kansas | 66606 | — |
| Novartis Investigator Site | Florence | Kentucky | 41017 | — |
| Novartis Investigator Site | Baltimore | Maryland | 21236 | — |
| Novartis Investigator Site | Wheaton | Maryland | 20902 | — |
| Novartis Investigator Site | North Dartmouth | Massachusetts | 02747 | — |
| Novartis Investigator Site | Ann Arbor | Michigan | 48106 | — |
| Novartis Investigator Site | Ypsilanti | Michigan | 48197 | — |
| Novartis Investigator Site | Springfield | Missouri | 65807 | — |
| Novartis Investigator Site | St Louis | Missouri | 63141 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68130 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68131 | — |
| Novartis Investigator Site | Northfield | New Jersey | 08225 | — |
| Novartis Investigator Site | Rockville Centre | New York | 11570 | — |
| Novartis Investigator Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigator Site | High Point | North Carolina | 27262 | — |
| Novartis Investigator Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigator Site | Cincinnati | Ohio | 45252 | — |
| Novartis Investigator Site | Toledo | Ohio | 43617 | — |
| Novartis Investigator Site | Edmond | Oklahoma | 73003 | — |
| Novartis Investigator Site | Oklahoma City | Oklahoma | 73120 | — |
| Novartis Investigator Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigator Site | Dallas | Texas | 75231 | — |
| Novartis Investigator site | Houston | Texas | 77024 | — |
| Novartis Investigator Site | Houston | Texas | 77030 | — |
| Novartis Investigator Site | Houston | Texas | 77054 | — |
| Novartis Investigator Site | Houston | Texas | 77070 | — |
| Novartis Investigator Site | Kirkland | Washington | 98034 | — |
| Novartis Investigator Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00529529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2011 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00529529 live on ClinicalTrials.gov.